Unitron Bio Medicals (UBM): Empowering Healthcare with Advanced Diagnostic Solutions and Technical Excellence

Prahalad BV, Founder

Prahalad BV

Founder

The medical diagnostics industry has become one of the most critical pillars of modern healthcare. As healthcare systems place greater emphasis on early disease detection, preventive medicine, precision diagnostics, and faster clinical decision-making, laboratories today require technology that delivers not only speed and accuracy but also long-term reliability.

India's diagnostic ecosystem is evolving rapidly, supported by growing healthcare investments, expanding hospital infrastructure, increasing laboratory automation, and government initiatives promoting domestic medical device manufacturing.

Within this evolving landscape, Unitron Bio Medicals (UBM) has steadily established itself as a trusted distributor and emerging manufacturer of advanced medical diagnostic equipment. Over nearly two decades, the company has transformed from a technical service organization into a comprehensive diagnostic solutions provider serving hospitals, diagnostic laboratories, medical colleges, and government healthcare institutions across India.

Built on deep technical expertise, long-standing customer relationships, global technology partnerships, and an expanding indigenous manufacturing capability, UBM continues to strengthen India's diagnostic infrastructure while preparing for the next generation of intelligent diagnostic technologies.

From Coffee Plantations to Healthcare Innovation

Success is rarely inherited; it is cultivated through perseverance, conviction, and the courage to build something meaningful from the ground up. Nestled amidst the mist-covered hills of Chikkamagaluru, Karnataka - India's renowned coffee capital generations of hardworking farming families have built their lives around patience, discipline, and perseverance.

It was in this environment that Prahalad BV spent his formative years, learning lessons that would shape his character long before he stepped into the world of healthcare technology.

Unlike many businesses that begin with product distri­bution, UBM was built from the ground up through technical service by Prahalad BV, an Electronics and Communication En­gineer, who entered the medical diagnostics industry immedi­ately after completing his education.

During the late 1990s and early 2000s, diagnostic laboratories across India were investing in increasingly sophisticated equipment. While these advanced instruments promised greater accuracy and efficiency, many healthcare institutions faced a significant challenge.

The availability of skilled professionals capable of installing, maintaining, calibrating, and servicing these systems was limited. Even the most advanced technology could become ineffective without dependable technical support.

Recognizing this gap, Prahalad BV initially focused on freelance servicing and technical support for diagnostic instruments. Rather than concentrating on commercial expansion, the priority was to ensure healthcare providers received dependable technical assistance whenever equipment failures disrupted laboratory operations.

Working closely with hospitals, diagnostic laboratories, pathologists, and laboratory professionals gave Prahalad a unique perspective on this gap. Every service call, every troubleshooting visit, and every customer interaction reinforced a simple but powerful realization: hospitals did not merely need equipment suppliers; they needed reliable technical partners who could ensure uninterrupted laboratory operations.

Unitron Bio Medicals has established itself as one of India's respected providers of In-Vitro Diagnostic (IVD) solutions, serving more than 6,000 hospitals, diagnostic laboratories, medical colleges, and healthcare institutions across the country

Prahalad BV, Founder

This insight would eventually define the philosophy that continues to distinguish Unitron Bio Medicals today.

The early experiences provided invaluable exposure to the practical realities of diagnostic laboratories. Working closely with pathologists, laboratory owners, clinicians, and hospital administrators enabled UBM to understand operational challenges beyond the equipment itself.

Rather than focusing solely on selling products, Prahalad concentrated on solving problems. He invested his time in understanding laboratory workflows, equipment performance, preventive maintenance, calibration, application support, and customer training. His approach was straightforward yet uncommon: build trust first, business later.

The results spoke for themselves.

Recognizing the opportunity to create an organization built on engineering excellence and customer trust, Unitron Bio Medicals (UBM) was formally established in 2006. Unlike many startups driven by aggressive expansion, UBM grew patiently.

Every milestone reflected careful planning, consistent reinvestment, and an unwavering commitment to quality. Instead of chasing rapid growth, the company concentrated on delivering reliable service and building lasting relationships with customers.

Creating Long-Term Value through Service Excellence

Healthcare providers today expect much more than high-performance diagnostic instruments. They require dependable partners capable of ensuring operational continuity, minimizing downtime, supporting laboratory personnel, and maintaining diagnostic accuracy throughout the life cycle of every instrument. This philosophy continues to define UBM.

Even as the company expanded its product portfolio, service remained its strongest differentiator. Installation support, preventive maintenance, calibration, application training, troubleshooting, and continuous technical engagement became integral to every customer relationship.

This customer-first philosophy became the company's greatest competitive advantage. As confidence in UBM continued to grow, hospitals and diagnostic centres increasingly requested complete diagnostic solutions rather than only engineering support. What had begun as a technical service organization gradually evolved into a comprehensive provider of in-vitro diagnostic (IVD) solutions.

Rather than abandoning its service roots, UBM strengthened them. Every new installation continued to be supported by preventive maintenance, calibration, application training, troubleshooting, and responsive engineering assistance. Customers appreciated knowing that behind every instrument stood a dedicated team committed to ensuring uninterrupted laboratory performance.

"This commitment to customer success has resulted in long-standing partnerships with healthcare institutions rather than transactional business relationships. Numerous hospitals, laboratories, and distributors have remained associated with UBM for several years, reflecting the trust the company has earned through responsive service and dependable support," says Prahalad BV.

Delivering Comprehensive Diagnostic Solutions

Today, Unitron Bio Medicals has established itself as one of India's respected providers of In-Vitro Diagnostic (IVD) solutions, serving more than 6,000 hospitals, diagnostic laboratories, medical colleges, and healthcare institutions across the country.

Supported by a dedicated team of nearly 85 employees and a network of more than 90 distributors, the company has earned a nationwide reputation for delivering not only advanced diagnostic systems but also dependable technical expertise that healthcare providers can rely upon every day.

However, the company's value proposition extends well beyond equipment supply. Every installation is supported through application guidance, quality control protocols, calibration support, preventive maintenance, and ongoing technical assistance. This becomes particularly important within the highly specialized IVD segment, where even minor deviations can influence diagnostic outcomes.

The company's consultative approach begins with understanding each laboratory's operational requirements before recommending appropriate technology. This customer-centric methodology has enabled UBM to participate in large-scale diagnostic infrastructure projects involving corporate hospital networks, medical colleges, government healthcare institutions, and laboratory chains.

Over the years, UBM has also established a strong and re­spected brand within India's medical diagnostics industry. Healthcare professionals recognize the company not only for the quality of its diagnostic equipment but also for its depend­able after-sales support, technical expertise, and customer-first approach.

This reputation has translated into high customer satisfaction, repeat business, and long-standing relationships with hospitals, laboratories, and channel partners.

From Distribution to Manufacturing: Preparing for the Future

Over the past few years, UBM has begun manufacturing semi-automated diagnostic systems and haematology reagents, while simultaneously investing in research and development for next-generation automated technologies.

The establishment of its modern manufacturing facility in Bengaluru represents one of the company's most significant milestones. Designed to strengthen production capabilities while maintaining stringent quality standards, the facility reflects UBM's commitment to developing world-class diagnostic technologies within India.

The company's manufacturing strategy closely aligns with India's 'Make in India' and 'Atmanirbhar Bharat' initiatives, contributing to the country's growing medical technology ecosystem.

For Prahalad BV, manufacturing represents far more than business expansion. It is an opportunity to create indigenous healthcare technologies that combine global standards with a deep understanding of Indian healthcare requirements.

By integrating engineering expertise, manufacturing excellence, and customer insights accumulated over nearly two decades, UBM is building solutions designed specifically for the evolving needs of hospitals and laboratories across the nation.

Preparing for the AI Era

Artificial Intelligence is expected to redefine laboratory diagnostics through intelligent workflow optimization, predictive analytics, enhanced automation, and improved clinical efficiency.

Recognizing this shift, UBM is actively working towards AI-enabled diagnostic platforms through collaborations with Indian and international technology partners.

The company's vision is not simply to introduce sophisticated technology but to make advanced diagnostics reliable, accessible, and affordable for healthcare providers throughout India. By combining intelligent software with robust engineering, UBM aims to support clinicians in making faster decisions while improving laboratory productivity and enhancing patient outcomes.

"Our long-term objective is to manufacture sophisticated automated diagnostic systems capable of competing globally while remaining accessible to Indian healthcare providers," says Prahalad BV.

Vision Ahead

Beyond manufacturing, UBM is also preparing for broader geographical expansion. Having established a strong presence across South India and built relationships with major healthcare institutions, the company now aims to strengthen its national footprint while exploring export opportunities in international markets.

As Unitron Bio Medicals prepares for its next phase of growth, its mission remains unchanged: to deliver advanced diagnostic technologies backed by exceptional service, enabling healthcare professionals to serve patients with greater confidence, accuracy, and care. By combining engineering excellence, indigenous manufacturing, and AI-driven innovation, UBM is well positioned to shape the future of diagnostic healthcare in India and beyond.

"Our journey has always been guided by one principle technology creates real value only when it is backed by exceptional service. As healthcare embraces automation and Artificial Intelligence, we remain committed to developing innovative diagnostic solutions that are reliable, accessible, and built to strengthen healthcare delivery across India and beyond”, signs off Prahalad BV.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

© 2026 India Pharma Outlook. All Rights Reserved.